Sort
82,697 grants matching “vaccine development”
Research Project 4: Mining human antibody responses to inform vaccine and therapeutic design
$2,202,045Jimmy D Gollihar · Albert Einstein College Of Medicine · U19 · FY2024 · AI
Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro
$2,200,798Mark M Davis · Stanford University · U19 · FY2024 · AI
Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro
$2,200,798Mark M Davis · Stanford University · U19 · FY2025 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$2,200,084James L. Sorensen · University Of California, San Francisco · UG1 · FY2019 · DA
Identification and validation of biomarkers of cervicovaginal mucosal alteration
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$2,200,000Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2017 · IP
Development of a SARS-CoV-2 vaccine for the elderly by engineering virus-like particles with SARS-CoV-2 antigen and membrane-anchored cytokines
$2,199,976Christopher Pack · Metaclipse Therapeutics Corporation · N44 · FY2020 · AI
Vaccination against mucosal HIV clade C transmission
$2,199,333Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2010 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS
$2,198,847Therion Biologics Corporation · P01 · FY2002 · AI
Bacterial genomics: multiscale investigation of host adaptation, unexplained resistance and plasmid dynamics
$2,198,637Ashlee Miriam Earl · Broad Institute, Inc. · U19 · FY2024 · AI
B Cells in Health and Disease
$2,198,492Ignacio E. Sanz · University Of Rochester · P01 · FY2010 · AI
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
$2,198,288Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
$2,198,134T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$2,197,512Barton F Haynes · Duke University · U19 · FY2022 · AI
Improving Research Resources at the TNPRC to Support COVID-19 Research
$2,197,136Lee Hamm · Tulane University Of Louisiana · P51 · FY2020 · OD
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D
$2,196,301David C Montefiori · Duke University · N01 · FY2014 · AI
CARIBBEAN PRIMATE RESEARCH CENTER
$2,196,299Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2014 · OD
SPORE in Skin Cancer
$2,195,541Meenhard Herlyn · Wistar Institute · P50 · FY2008 · CA
Mayo Clinic Breast Cancer SPORE
$2,194,603James Newell Ingle · Mayo Clinic Rochester · P50 · FY2006 · CA
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
$2,194,290James Culvin Morris · Clemson University · P20 · FY2025 · GM
Adeno-associated Virus Biology And Utilization For Gene Transfer
$2,194,150Jay Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Enhanced Surveillance for New Vaccine Preventable Diseases
$2,193,828Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2020 · IP
Project 1: Immune Memory
$2,193,601Rafi Ahmed · Emory University · U19 · FY2020 · AI
Integrative analysis and modeling of human immune responses and pathologies
$2,192,745John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
$2,191,859Matthew Eugene Pipkin · University Of Florida · P01 · FY2023 · AI